T Cell Response to Infliximab in Exposed Patients: A Longitudinal Analysis.
Pratesi S, Nencini F, Grosso F, Dies L, Bormioli S, Cammelli D, Maggi E, Matucci A, Vultaggio A; ABIRISK Consortium.
Pratesi S, et al. Among authors: bormioli s.
Front Immunol. 2019 Jan 11;9:3113. doi: 10.3389/fimmu.2018.03113. eCollection 2018.
Front Immunol. 2019.
PMID: 30687319
Free PMC article.